← Leaderboards
Christoforos Thomas
Methodist Hospital Research Institute
$2,239,530
Attributed
$2,239,530
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $605.2K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,239,530 · 2
By mechanism
R01$1,844,871 · 1
R21$394,659 · 1
Top collaborators
No co-investigators on record.
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Dan Theodorescu$43,145,134
- Junhua Mai$789,361
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsSpecimenAgonistMortalityPhenotypeSignal TransductionTumorKnock-OutLigandsMediatingEnsurePathway InteractionsAffectReceptorEstrogensOncogenicIn VivoIncidenceCellsClinical TrialsMalignant Breast NeoplasmEstrogen Receptor BetaEstrogen Receptor AlphaGenes
Grant awards (9)
Exploring the role of estrogen receptor beta in progression and metastasis ofInflammatory breast cancer$350,960
R01 · FY2024 · CA · contact PI
Exploring the role of estrogen receptor beta in progression and metastasis ofInflammatory breast cancer$362,043
R01 · FY2023 · CA · contact PI
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome$166,753
R21 · FY2023 · CA · contact PI
Exploring the role of estrogen receptor beta in progression and metastasis ofInflammatory breast cancer$240,894
R01 · FY2022 · CA · contact PI
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome$223,282
R21 · FY2022 · CA · contact PI
Exploring the role of estrogen receptor beta in progression and metastasis of Inflammatory breast cancer$136,406
R01 · FY2022 · CA · contact PI
Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome$4,624
R21 · FY2022 · CA · contact PI
Exploring the role of estrogen receptor beta in progression and metastasis of Inflammatory breast cancer$370,400
R01 · FY2021 · CA · contact PI
Exploring the role of estrogen receptor beta in progression and metastasis of Inflammatory breast cancer$384,168
R01 · FY2020 · CA · contact PI